<DOC>
	<DOCNO>NCT02326051</DOCNO>
	<brief_summary>Evaluation effect alter time initiation low molecular weight heparin ( LMWH ) administration pregnancy outcome woman antiphospholipid syndrome ( APS )</brief_summary>
	<brief_title>Timing Initiation LMWH Administration Pregnant Women With APS</brief_title>
	<detailed_description>Women randomly divide two group ; one start Enoxaparin therapy positive pregnancy test establish start Enoxaparin therapy sonographic confirmation fetal cardiac pulsation . In woman , Enoxaparin give dose 40 mg/day subcutaneously therapy continue termination pregnancy</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Antiphospholipid Syndrome</mesh_term>
	<mesh_term>Abortion , Habitual</mesh_term>
	<criteria>Pregnant woman APS diagnose accord revise classification criterion APS 2006 Sydney , Australia Early pregnancy body weight 5090 Kg Women systemic lupus erythematosus ( SLE ) Women active thromboembolic disorder Women history previous thromboembolic disorder</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Antiphospholipid syndrome</keyword>
	<keyword>APS</keyword>
	<keyword>LMWH</keyword>
</DOC>